MedinCell S.A. (MDCLF)
MDCLF Stock Price Chart
Explore MedinCell S.A. interactive price chart. Choose custom timeframes to analyze MDCLF price movements and trends.
MDCLF Company Profile
Discover essential business fundamentals and corporate details for MedinCell S.A. (MDCLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Jan 2021
Employees
131.00
Website
https://www.medincell.comCEO
Christophe Douat
Description
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France.
MDCLF Financial Timeline
Browse a chronological timeline of MedinCell S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 9 Dec 2025
Earnings released on 17 Jun 2025
EPS came in at -$0.13 surpassing the estimated -$0.45 by +71.43%, while revenue for the quarter reached $18.82M , beating expectations by +269.09%.
Earnings released on 3 Dec 2024
EPS came in at -$0.56 , while revenue for the quarter reached $9.60M , beating expectations by +113.28%.
Earnings released on 25 Jun 2024
EPS came in at -$0.63 , while revenue for the quarter reached $4.04M , missing expectations by -64.30%.
Earnings released on 21 Dec 2023
EPS came in at -$0.31 , while revenue for the quarter reached $7.37M .
Earnings released on 31 Mar 2023
EPS came in at -$0.79 , while revenue for the quarter reached $4.20M .
Earnings released on 30 Sept 2022
EPS came in at -$0.53 , while revenue for the quarter reached $5.89M .
Earnings released on 31 Mar 2022
EPS came in at -$0.58 , while revenue for the quarter reached $2.75M .
Earnings released on 30 Sept 2021
EPS came in at -$0.55 , while revenue for the quarter reached $1.86M .
Earnings released on 31 Mar 2021
EPS came in at -$0.21 , while revenue for the quarter reached $5.93M .
Earnings released on 30 Sept 2020
EPS came in at -$0.30 , while revenue for the quarter reached $3.69M .
MDCLF Stock Performance
Access detailed MDCLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.